We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.14B
AUM Growth
-$171M
Cap. Flow
-$231M
Cap. Flow %
-7.38%
Top 10 Hldgs %
16.05%
Holding
444
New
72
Increased
89
Reduced
94
Closed
73

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$29.5M
2
MIDD icon
Middleby
MIDD
+$25.9M
3
PH icon
Parker-Hannifin
PH
+$25.1M
4
VEEV icon
Veeva Systems
VEEV
+$23M
5
DKS icon
Dick's Sporting Goods
DKS
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 19.27%
2 Energy 16.11%
3 Healthcare 14.04%
4 Industrials 13.84%
5 Consumer Discretionary 11.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSX icon
301
Phillips 66
PSX
$106B
$830K 0.03%
9,610
BA icon
302
Boeing
BA
$160B
$778K 0.02%
5,000
EQNR icon
303
Equinor
EQNR
$105B
$755K 0.02%
41,390
CEO
304
DELISTED
CNOOC Limited
CEO
$754K 0.02%
6,080
XRAY icon
305
Dentsply Sirona
XRAY
$2.02B
$740K 0.02%
12,820
MON
306
DELISTED
Monsanto Co
MON
$644K 0.02%
6,120
SEE
307
DELISTED
Sealed Air
SEE
$628K 0.02%
13,840
CRZO
308
DELISTED
Carrizo Oil & Gas Inc
CRZO
$627K 0.02%
16,780
ET icon
309
Energy Transfer Partners
ET
$72.7B
$620K 0.02%
+32,100
New +$536K
MUSA icon
310
Murphy USA
MUSA
$9.43B
$538K 0.02%
8,745
-7,900
-47% -$532K
SQM icon
311
Sociedad Química y Minera de Chile
SQM
$19.6B
$537K 0.02%
18,750
+8,950
+91% +$254K
TJX icon
312
TJX Companies
TJX
$135B
$514K 0.02%
13,680
LKFT
313
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
$506K 0.02%
7,890
+4,560
+137% +$281K
HOG icon
314
Harley-Davidson
HOG
$2.79B
$488K 0.02%
8,363
C icon
315
Citigroup
C
$223B
$476K 0.02%
8,010
QCOM icon
316
Qualcomm
QCOM
$197B
$453K 0.01%
6,950
KO icon
317
Coca-Cola
KO
$378B
$415K 0.01%
10,020
RDC
318
DELISTED
Rowan Companies Plc
RDC
$413K 0.01%
21,880
SIMO icon
319
Silicon Motion
SIMO
$8.18B
$412K 0.01%
9,710
+5,610
+137% +$256K
BWA icon
320
BorgWarner
BWA
$12.7B
$408K 0.01%
11,746
AXP icon
321
American Express
AXP
$211B
$383K 0.01%
5,175
MYGN icon
322
Myriad Genetics
MYGN
$369M
$379K 0.01%
22,760
NBR icon
323
Nabors Industries
NBR
$1.3B
$367K 0.01%
448
PCAR icon
324
PACCAR
PCAR
$62.2B
$367K 0.01%
8,625
DBVT
325
DBV Technologies
DBVT
$741M
$340K 0.01%
969
+560
+137% +$201K

Similar funds

Castleark Management's Q4 2016 Portfolio in Review

As of Q4 2016, Castleark Management held 444 positions worth $3.14B, down 5.2% from $3.31B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Castleark Management withdrew a net $231M in Q4 2016, closing 73 positions and reducing 94 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Castleark Management opened a new position in Morgan Stanley worth $32.9M.

  • Castleark Management's largest Q4 2016 buy was Morgan Stanley: 779,714 shares worth $32.9M.
  • Castleark Management added most to Middleby in Q4 2016, an estimated $25.9M increase.
  • Castleark Management's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $43.4M.
  • Castleark Management fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $22.8M.
  • Castleark Management's ten largest holdings make up 16% of its $3.14B portfolio in Q4 2016.
  • Castleark Management opened 72 new positions and closed 73 in Q4 2016.
  • Castleark Management's portfolio value fell 5.2% quarter-over-quarter to $3.14B.

Based on Castleark Management's 13F filing for Q4 2016, filed 15 Feb 2017.